GoHealth Reports Catastrophic 94.6% Revenue Decline, Negative Adjusted EBITDA, and Reiterates Going Concern Warning
Summary
GoHealth reported a catastrophic 94.6% year-over-year revenue decline and a swing to negative Adjusted EBITDA for Q1 2026, further deepening its financial distress. Management reiterated substantial doubt about its ability to continue as a going concern and expects to breach liquidity covenants, while facing a significant Department of Justice lawsuit.
Key Events
-
Catastrophic Revenue Decline
Net revenues for Q1 2026 plummeted 94.6% year-over-year to $11.91 million, down from $220.97 million in Q1 2025.
-
Widening Losses and Negative Adjusted EBITDA
Net loss attributable to GoHealth, Inc. widened to $37.17 million from $4.41 million in Q1 2025. Adjusted EBITDA swung from a positive $42.06 million in Q1 2025 to a negative $22.22 million in Q1 2026.
-
Going Concern Warning Reiterated with Liquidity Crisis
Management reiterated 'substantial doubt' about the company's ability to continue as a going concern within the next twelve months, stating it is 'probable' they will be unable to maintain compliance with their minimum liquidity covenant.
-
Major Legal Setback in DOJ Lawsuit
Motions to dismiss were 'denied substantially all' on March 25, 2026, in a Department of Justice lawsuit alleging False Claims Act and Anti-Kickback Statute violations, with potential for 'material' damages.
Analysis
GoHealth's Q1 2026 results reveal a dramatic acceleration of its financial distress, with revenues collapsing by 94.6% year-over-year and Adjusted EBITDA swinging sharply negative. This severe operational deterioration, coupled with management's explicit warning of a probable liquidity covenant breach and ongoing restructuring discussions, intensifies the existing 'going concern' risk. The denial of motions to dismiss in the Department of Justice lawsuit adds another layer of significant, unquantifiable legal risk, making the company's path forward extremely challenging.
At the time of this filing, GOCO was trading at $0.82 on NASDAQ in the Finance sector, with a market capitalization of approximately $24.9M. The 52-week trading range was $0.83 to $7.38. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.